20490 ⎘
Medicinal preparations containing organic active ingredients; Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
CATALYTIC INHIBITOR OF PROTEIN PHOSPHATASE 5 ACTIVATES THE EXTRINSIC APOPTOTIC PATHWAY BY DISRUPTING COMPLEX II
#2PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES WITH HIGH PENETRATION PRODRUGS OF ASPIRIN AND OTHER NSAIDS
#3NEW COMBINATION DRUG FOR TREATING CORONAVIRUS INFECTIONS, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#4HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS
#5HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS
#6DIPHENHYDRAMINE AND LACTOFERRIN FOR PREVENTION AND TREATMENT OF COVID-19
#7HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS
#8SYNERGISTIC ANTIBACTERIAL ACTIVITY OF MEDIUM POLARITY OILS IN COMBINATION WITH ANTIBACTERIAL AGENTS ON BACTERIAL BIOFILMS
#9PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES
#10Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms
#11PHARMACEUTICAL COMBINATIONS COMPRISING INSULIN AND AT LEAST AN AGENT SELECTED FROM MELOXICAM, BROMFENAC SODIUM, ACETYLSALICYLIC ACID, SALICYCLIC ACID AND PARACETAMOL
#12Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
#13COMPOUNDS FOR THE TREATMENT OF DISEASES CAUSED BY OXALATE ACCUMULATION
#14PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES
#15Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms
#16CYCLIC AMINES
#17High penetration prodrug compositions and pharmaceutical compositon thereof for treatment of pulmonary conditions
#18Method for inhibiting growth of cancer cells
#19Prevention and treatment for microbial infections
#20Cyclic amines
#21Methods and compositions to treat type-1 and type-2 diabetes
#22COMPOSITIONS AND METHODS FOR DETECTING SNP(S) ASSOCIATED WITH DIABETES
#23Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
#24Crystals and process of making 5-({[2-amino-3-(4-Carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
#25Cyclic amines
#26Method for a Wellbeing Therapy Program
#27TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
#28FORMULATION AND DOSING OF HSP90 INHIBITORY COMPOUNDS
#29Method for inhibiting growth of cancer cells
#30High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
#31Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression
#32Imidazopyridazine compounds
#33Methods for treating or preventing restenosis and other vascular proliferative disorders
#34ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER
#35N-acyl anthranilic acid derivative or salt thereof
#36Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
#37ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER
#38TREATMENTS WITH HELMINTHS
#39Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
#40Methods for treating or preventing restenosis and other vascular proliferative disorders
#41Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
#42Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids